Phenanthroline

Phenanthroline

SCHEMBL23829939

C1=Nc2cccc3cccc(c23)N1.c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 0.73
LMNA P02545 4/20 0.48
CCR1 P32246 3/20 0.48
CCR5 P51681 3/20 0.48
CCR8 P51685 3/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 3/20 0.48
MMP2 P08253 2/20 0.48
TSHR P16473 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
GMNN O75496 1/20 0.48
TP53 P04637 1/20 0.48
HSP90AA1 P07900 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MMP9 P14780 1/20 0.48
ALOX15 P16050 1/20 0.48
NFKB1 P19838 1/20 0.48
MMP8 P22894 1/20 0.48
THPO P40225 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8112 0.85 GRK6 (1.00) GRK6LMNAMAPTKDM4ETDP1
SCHEMBL29778809 0.85 GRK6 (1.00) GRK6LMNAMAPTKDM4ETDP1
Bromide SCHEMBL31741343 0.84 GRK6 (0.96) GRK6LMNAMAPTKDM4ETSHR
Hydrochloric Acid SCHEMBL11423019 0.84 GRK6 (0.96) GRK6LMNAMAPTKDM4ETDP1
SCHEMBL27475210 0.83 GRK6 (0.75) GRK6LMNAMAPTKDM4EMMP2
Formaldehyde SCHEMBL27694578 0.80 GRK6 (0.89) GRK6LMNAMAPTKDM4ETDP1
SCHEMBL27746989 0.77 GRK6 (0.75) GRK6LMNAMAPTKDM4ETDP1
Benzoquinone SCHEMBL28256504 0.76 GRK6 (0.80) GRK6LMNAMAPTKDM4ETDP1
Uracil SCHEMBL27474818 0.75 GRK6 (0.67) GRK6LMNAMAPTKDM4ETDP1
Acetic Acid SCHEMBL15018560 0.75 GRK6 (0.77) GRK6LMNAMAPTKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292298-A1 BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR DBD THERAPEUTICS, LLC 2021-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292298-A1 BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR AR, ADRM1, PSMA3 GRK6 343/4885LMNA 3294/4885CCR1 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.